AI assistant
Crescent NV Major Shareholding Notification 2026
3935_mrq_2026-02-20_b4a21281-56c4-4f59-9a95-a08b43690130.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
{0}------------------------------------------------
REGULATED INFORMATION -
Disclosure of a transparency notification (Article 14, first paragraph, of the Act of 2 May 2007 on the disclosure of major shareholdings)
Leuven, Belgium – 20 February 2026 – 7:30 AM CET, Option NV, Geldenaaksebaan 329, 3001 Heverlee (Euronext Brussels: OPTI) – received on 18 February 2026 a transparency notification from DANLAW Inc and Raju Dandu indicating that the participation threshold of 5% has been undercut. The relevant details of this transparency notification are as follows:
DANLAW Inc and Raju Dandu
Reason for notification:
Passive crossing of a threshold
Notification by:
A parent undertaking or a controlling person.
Person subject to notification:
DANLAW Inc., 41131 Vincenti Ct. Novi, MI 48375, USA Raju Dandu
Date of threshold crossing:
30/12/2025
Threshold crossed:
This resulted in the combined threshold of 5% being crossed.
Denominator: total number of shares:
2,534,641,145
Detail of the notification
| Previous notification | After the transaction | |||
|---|---|---|---|---|
| # Voting rights | # Voting rights | % Voting rights | ||
| Linked to securities | Separate from securities |
Linked to securities |
Separate from securities |
|
| 0 | 0 | 0 | 0.00% | 0.00% |
| 103,838,830 | 103,838,830 | 0 | 4.10% | 0.00% |
| TOTAL | 103,838,830 | 0 | 4.10% | 0.00% |
{1}------------------------------------------------
Full chain of controlled companies through which the shareholding is actually held:
Raju DANDU controls DANLAW Inc.
Additional information:
More details are available on the OPTION website: https://www.option.com/.
In accordance with the articles of association, the threshold above which a shareholding must be disclosed has been set at 3%.
CONTACT
Edwin Bex Geldenaaksebaan 329 B-3001 Leuven, Belgium TEL: +32 (0) 16 31 74 11
E-mail: [email protected]